Panaxia

Medical Cannabis Products

Health Tech & Life Sciences
Acquired by Barak Investment House
Public Lod, Israel Founded 2009
Last updated 2026-06-18
Total raised
$11.6M
Last: 2024-01
Stage
Public
Founded
2009
Headcount
54
HQ
Lod, Israel
Sector
Health Tech & Life Sciences

About

Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis. The company's goal is to align medical cannabis with formulation technologies and the highest available pharmaceutical standards. Panaxia currently manufactures a variety of standardized medical cannabis products including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories. The company's products, manufacturing facility, and production processes are subject to stringent quality assurance procedures. Panaxia is part of the Panaxia Medical Devices and Pharmaceuticals Group. Panaxia's R&D center is located in Israel and is managed by senior scientists and graduates of the Weizmann Institute of Science. Panaxia offers more than 600 medical products in over 30 international markets to treat a wide range of symptoms and conditions.

Funding history · 3 rounds · $11.6M total

Q&A

What is Panaxia's primary business?
Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis products, including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories.
When was Panaxia acquired and by whom?
Panaxia was acquired by Barak Investment House in March 2024.
What was Panaxia's last known funding round?
Panaxia's last funding round was in January 2024, raising $270,000.
Who are the founders of Panaxia?
Dadi Segal is a Co-founder and CEO of Panaxia.
In which countries does Panaxia offer its medical products?
Panaxia offers its medical products in over 30 international markets, including France, Greece, Israel, Poland, Malta, Portugal, Australia, Germany, and Cyprus.
What is the total amount of funding Panaxia has raised to date?
Panaxia has raised a total of $11,598,700.
What is the primary sector of Panaxia?
Panaxia's primary sector is Health Tech & Life Sciences.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2CB2B

Highlights

1 Patents

Tags

biotechnologypharmaceuticalsbiopharmaceuticalcannabispain-reliefmedical-cannabistopical-treatment
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepanaxia.co.il
LinkedInlinkedin.com/company/13211586
YouTubeyoutube.com/channel/UCXgmFMQ71xgbn_uQXW_4AGg
Wikipediaen.wikipedia.org/wiki/Panaxia
Wikidatawikidata.org/wiki/Q108057168

Identifiers & details

Founded2009-9
Employees (exact)54
Status reasonAcquired by Barak Investment House on Mar, 2024
Wikidata QIDQ108057168

Acquisitions & public offerings

Acquired by Barak Investment House 2024-03

Radar intelligence

Patents

EPO29

Publications (Crossref)

Works1

Web history (Wayback)

Domainpanaxia.co.il

Wikidata

QIDQ108057168

Certificate / subdomain footprint

Subdomains65